Ifosfamide chemotherapy in cats with vaccine associated sarcoma
21 May 2009
No Comment
Status: Closed 5/31/02
Eligibility:
Eligibility:
* Measurable disease
* No previous chemotherapy or radiation therapy
* No underlying renal or hepatic disease
Ifosfamide chemotherapy in cats with vaccine associated sarcoma
Trial Support: The majority of costs associated with chemotherapy treatment and follow up will be provided by the trial sponsor (Cornell University; Vaccine associated sarcoma task force - AVMA). Entry to the trial can be undertaken at several participating veterinary centers across the United States including all centers in the Animal Cancer Institute Network.
Pet owners seeking novel treatment options for animals with serious health conditions find an Animal Clinical Investigation network veterinarian participating in a clinical trial.
Animal Clinical Investigation network veterinarian and pet owner work together to determine whether the pet is eligible for the trial. Eligible pets begin treatment at an ACI network hospital.
Information from the trial is used to help develop new drugs and treatments, providing a source of hope for people whose pets face serious illnesses.